Skip to content

NRx & HOPE Therapeutics Present Innovative Mental Health Solutions at Noble Capital Markets Conference

Discover NRx's and HOPE's latest mental health therapies. Learn about their recent collaborations and clinical operations expansion.

In this image I can see many drugs which are placed on the floor.
In this image I can see many drugs which are placed on the floor.

NRx & HOPE Therapeutics Present Innovative Mental Health Solutions at Noble Capital Markets Conference

NRx Pharmaceuticals and its subsidiary, HOPE Therapeutics, are set to present at the Noble Capital Markets Emerging Growth Virtual Equity Conference on October 8, 2025. The presentation will discuss the companies' innovative treatments for depression and other mental health disorders, including a new low-dose D-Cycloserine product to enhance TMS effectiveness.

The presentation, led by NRx Pharmaceuticals' Co-CEOs Jonathan Javitt, M.D., M.P.H., and Matthew Duffy, will delve into HOPE Therapeutics' network of interventional psychiatry clinics offering ketamine, TMS, Hyperbaric Oxygen Therapy, and other therapies for patients with suicidal depression and related disorders. Dr. Javitt will also provide a corporate update, including the recent refiling of an Abbreviated New Drug Application (ANDA) for NRX-100, a preservative-free intravenous ketamine, and NRX-101, an oral D-cycloserine/lurasidone combination for treating central nervous system disorders such as suicidal depression, chronic pain, and PTSD.

The presentation will also highlight HOPE Therapeutics' recent participation in the Stop Suicide summit and Dr. Javitt's keynote presentation at the US Army Museum. Additionally, it will provide details on the company's newly-acquired clinical operations in Florida and its active collaboration with the US Department of Veterans Affairs.

The presentation, available via live webcast to registered attendees and as a replay on the company's website post-event, is expected to offer valuable insights into NRx Pharmaceuticals' and HOPE Therapeutics' cutting-edge approaches to mental health treatment. Management will also be available for one-on-one investor meetings throughout the conference.

Read also:

Latest